BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36318757)

  • 1. Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers.
    Meher N; Ashley GW; Bidkar AP; Dhrona S; Fong C; Fontaine SD; Beckford Vera DR; Wilson DM; Seo Y; Santi DV; VanBrocklin HF; Flavell RR
    ACS Appl Mater Interfaces; 2022 Nov; 14(45):50569-50582. PubMed ID: 36318757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer.
    Meher N; Ashley GW; Bobba KN; Wadhwa A; Bidkar AP; Dasari C; Mu C; Sankaranarayanan RA; Serrano JAC; Raveendran A; Bulkley DP; Aggarwal R; Greenland NY; Oskowitz A; Wilson DM; Seo Y; Santi DV; VanBrocklin HF; Flavell RR
    Adv Healthc Mater; 2024 May; ():e2304618. PubMed ID: 38700450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen.
    Meher N; Seo K; Wang S; Bidkar AP; Fogarty M; Dhrona S; Huang X; Tang R; Blaha C; Evans MJ; Raleigh DR; Jun YW; VanBrocklin HF; Desai TA; Wilson DM; Ozawa T; Flavell RR
    ACS Appl Mater Interfaces; 2021 Nov; 13(46):54739-54752. PubMed ID: 34752058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Uptake of Triazine Dendrimers Decorated with Four, Sixteen, and Sixty-Four PSMA-Targeted Ligands: Passive versus Active Tumor Targeting.
    Lim J; Guan B; Nham K; Hao G; Sun X; Simanek EE
    Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31466360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
    Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M
    J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Banerjee SR; Foss CA; Horhota A; Pullambhatla M; McDonnell K; Zale S; Pomper MG
    Biomacromolecules; 2017 Jan; 18(1):201-209. PubMed ID: 28001364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small Molecule, Multimodal, [
    Aras O; Demirdag C; Kommidi H; Guo H; Pavlova I; Aygun A; Karayel E; Pehlivanoglu H; Yeyin N; Kyprianou N; Chen N; Harmsen S; Sonmezoglu K; Lundon DJ; Oklu R; Ting R; Tewari A; Akin O; Sayman HB
    Clin Genitourin Cancer; 2021 Oct; 19(5):405-416. PubMed ID: 33879400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation.
    Lesniak WG; Boinapally S; Lofland G; Jiang Z; Foss CA; Behman Azad B; Jablonska A; Garcia MA; Brzezinski M; Pomper MG
    Int J Nanomedicine; 2024; 19():4995-5010. PubMed ID: 38832336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway.
    Zhang H; Liu X; Wu F; Qin F; Feng P; Xu T; Li X; Yang L
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin-Binding PSMA Ligands: Implications for Expanding the Therapeutic Window.
    Kelly JM; Amor-Coarasa A; Ponnala S; Nikolopoulou A; Williams C; DiMagno SG; Babich JW
    J Nucl Med; 2019 May; 60(5):656-663. PubMed ID: 30552199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors.
    Ngen EJ; Chen Y; Azad BB; Boinapally S; Jacob D; Lisok A; Shen C; Hossain MS; Jin J; Bhujwalla ZM; Pomper MG; Banerjee SR
    Nanotheranostics; 2021; 5(2):182-196. PubMed ID: 33564617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile.
    Benešová M; Umbricht CA; Schibli R; Müller C
    Mol Pharm; 2018 Mar; 15(3):934-946. PubMed ID: 29400475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [(18)F]Fluoroethyl Triazole Substituted PSMA Inhibitor Exhibiting Rapid Normal Organ Clearance.
    Chen Y; Lisok A; Chatterjee S; Wharram B; Pullambhatla M; Wang Y; Sgouros G; Mease RC; Pomper MG
    Bioconjug Chem; 2016 Jul; 27(7):1655-62. PubMed ID: 27270097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.
    Chen Y; Pullambhatla M; Foss CA; Byun Y; Nimmagadda S; Senthamizhchelvan S; Sgouros G; Mease RC; Pomper MG
    Clin Cancer Res; 2011 Dec; 17(24):7645-53. PubMed ID: 22042970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of
    Potemkin R; Strauch B; Kuwert T; Prante O; Maschauer S
    Mol Pharm; 2020 Mar; 17(3):933-943. PubMed ID: 32011889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity.
    Deberle LM; Benešová M; Umbricht CA; Borgna F; Büchler M; Zhernosekov K; Schibli R; Müller C
    Theranostics; 2020; 10(4):1678-1693. PubMed ID: 32042329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacious delivery of protein drugs to prostate cancer cells by PSMA-targeted pH-responsive chimaeric polymersomes.
    Li X; Yang W; Zou Y; Meng F; Deng C; Zhong Z
    J Control Release; 2015 Dec; 220(Pt B):704-14. PubMed ID: 26348387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy.
    Kiess AP; Minn I; Vaidyanathan G; Hobbs RF; Josefsson A; Shen C; Brummet M; Chen Y; Choi J; Koumarianou E; Baidoo K; Brechbiel MW; Mease RC; Sgouros G; Zalutsky MR; Pomper MG
    J Nucl Med; 2016 Oct; 57(10):1569-1575. PubMed ID: 27230930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and preliminary evaluation of
    Vaidyanathan G; Mease RC; Minn I; Choi J; Chen Y; Shallal H; Kang CM; McDougald D; Kumar V; Pomper MG; Zalutsky MR
    Nucl Med Biol; 2021; 94-95():67-80. PubMed ID: 33601187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Polymeric Nanomedicines Targeted to PSMA: Effect of Ligand on Targeting Efficiency.
    Fuchs AV; Tse BW; Pearce AK; Yeh MC; Fletcher NL; Huang SS; Heston WD; Whittaker AK; Russell PJ; Thurecht KJ
    Biomacromolecules; 2015 Oct; 16(10):3235-47. PubMed ID: 26335533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.